← Back to Search

Pulmonary Rehabilitation for Lung Cancer

Phase 2
Waitlist Available
Led By Vickie Shannon, BS,MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with anatomically resectable lung tumors who are deemed surgically inoperable based on preoperative pulmonary function testing FEV1 < 80% pred; DLCO < 80% pred; FEV1ppo < 40% pred; DLCO ppo < 40% pred AND VO2 peak < 60% predicted or < 15 ml/kg/min
Patients deemed surgically inoperable based on poor performance status (ECOG score 2-3)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial is testing whether pulmonary rehabilitation can help people with poor lung function become eligible for surgery, and whether it improves health after surgery.

Who is the study for?
This trial is for lung cancer patients who can't have surgery due to poor lung function or other health issues but are otherwise stable. They should be able to perform some exercise without severe heart problems, not have bone metastasis, severe pulmonary hypertension, serious heart failure, or active psychiatric illness that could interfere.Check my eligibility
What is being tested?
The study is testing if a program of pulmonary rehabilitation (special exercises and therapies for the lungs) before surgery can improve lung function enough to make patients eligible for surgery and help them recover better after the operation.See study design
What are the potential side effects?
Pulmonary rehabilitation generally has minimal side effects but may include muscle soreness and fatigue. The questionnaire poses no physical risks but might cause emotional discomfort if sensitive topics are discussed.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My lung function tests show I can't have surgery for my lung tumor.
Select...
I am considered not fit for surgery due to my limited ability to perform daily activities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Treatment Success (conversion from ineligible to eligible status for lung resection following Pulmonary rehabilitation (PR))
Secondary outcome measures
Examine health of pulmonary rehabilitation participants after surgery.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pulmonary RehabilitationExperimental Treatment2 Interventions
Pulmonary Rehabilitation - Rehabilitation treatment given over about 3-4 weeks. Questionnaire regarding quality-of-life that lasts about 30 minutes.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pulmonary Rehabilitation
2011
Completed Phase 4
~1640

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,966 Previous Clinical Trials
1,804,706 Total Patients Enrolled
Vickie Shannon, BS,MDPrincipal InvestigatorM.D. Anderson Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Pulmonary Rehabilitation generally regarded as secure for individuals?

"The safety of Pulmonary Rehabilitation was evaluated as a 2 on our scale due to the fact that it is in Phase 2 trials and there are some findings demonstrating its security, but no reports confirming efficacy."

Answered by AI

Are there still opportunities to partake in this research endeavor?

"According to clinicaltrials.gov, this medical trial is not currently accepting participants. The study was first posted in January 2008 and has had its details updated most recently on December 6th 2022. Despite this particular research project having stalled, there are 1636 other studies presently recruiting patients across the globe."

Answered by AI
~6 spots leftby Sep 2025